Norges Bank
AGIO icon

Norges Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Norges Bank’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,756
Closed -$225K – 43
2025
Q2 		$225K Sell
6,756
-70,788
-91% -$2.15M ﹤0.01% 1687
2025
Q1 		$2.27M Sell
77,544
-67,548
-47% -$2.24M ﹤0.01% 1501
2024
Q4 		$4.77M Sell
145,092
-30,763
-17% -$1.45M ﹤0.01% 1511
2024
Q3 		$7.81M Sell
175,855
-66,879
-28% -$3.04M ﹤0.01% 1420
2024
Q2 		$10.5M Sell
242,734
-19,723
-8% -$712K ﹤0.01% 1389
2024
Q1 		$7.67M Sell
262,457
-44,069
-14% -$1.18M ﹤0.01% 1527
2023
Q4 		$6.83M Buy
306,526
+60,622
+25% +$1.36M ﹤0.01% 1600
2023
Q3 		$6.09M Buy
245,904
+42,775
+21% +$1.13M ﹤0.01% 1637
2023
Q2 		$5.75M Sell
203,129
-77,640
-28% -$1.93M ﹤0.01% 1687
2023
Q1 		$6.45M Sell
280,769
-72,733
-21% -$1.93M ﹤0.01% 1693
2022
Q4 		$9.93M Hold
353,502
– – ﹤0.01% 1576
2022
Q3 		$10M Sell
353,502
-122,231
-26% -$3.28M ﹤0.01% 1542
2022
Q2 		$10.5M Sell
475,733
-20,159
-4% -$455K ﹤0.01% 1538
2022
Q1 		$14.4M Buy
495,892
+290,246
+141% +$8.87M ﹤0.01% 1554
2021
Q4 		$6.76M Sell
205,646
-89,911
-30% -$3.62M ﹤0.01% 1858
2021
Q3 		$13.6M Sell
295,557
-96,034
-25% -$4.64M ﹤0.01% 1655
2021
Q2 		$21.6M Buy
391,591
+121,689
+45% +$6.8M ﹤0.01% 1489
2021
Q1 		$13.9M Sell
269,902
-299,934
-53% -$14.9M ﹤0.01% 1683
2020
Q4 		$24.7M Buy
569,836
+12,211
+2% +$483K 0.01% 1438
2020
Q3 		$19.5M Sell
557,625
-373,896
-40% -$16.4M 0.01% 1441
2020
Q2 		$49.8M Sell
931,521
-112,333
-11% -$5.2M 0.01% 837
2020
Q1 		$37M Hold
1,043,854
– – 0.01% 851
2019
Q4 		$49.8M Buy
1,043,854
+550,000
+111% +$20.8M 0.01% 921
2019
Q3 		$16M Buy
493,854
+76,029
+18% +$3.15M ﹤0.01% 1598
2019
Q2 		$20.8M Hold
417,825
– – 0.01% 1477
2019
Q1 		$28.2M Hold
417,825
– – 0.01% 1258
2018
Q4 		$19.3M Buy
417,825
+51,349
+14% +$3.17M 0.01% 1427
2018
Q3 		$28.3M Hold
366,476
– – 0.01% 1307
2018
Q2 		$30.9M Hold
366,476
– – 0.01% 1216
2018
Q1 		$30M Buy
366,476
+50,000
+16% +$3.86M 0.01% 1150
2017
Q4 		$18.1M Hold
316,476
– – 0.01% 1522
2017
Q3 		$21.1M Sell
316,476
-301,158
-49% -$18.1M 0.01% 1404
2017
Q2 		$31.8M Sell
617,634
-10,393
-2% -$531K 0.01% 1074
2017
Q1 		$36.7M Buy
628,027
+430,416
+218% +$20.6M 0.02% 913
2016
Q4 		$8.25M Sell
197,611
-24,086
-11% -$1.26M ﹤0.01% 1756
2016
Q3 		$11.2M Hold
221,697
– – 0.01% 1589
2016
Q2 		$9.29M Buy
221,697
+120,966
+120% +$5.97M ﹤0.01% 1653
2016
Q1 		$4.09M Sell
100,731
-54,879
-35% -$2.35M ﹤0.01% 1895
2015
Q4 		$10.1M Sell
155,610
-13,439
-8% -$881K 0.01% 1582
2015
Q3 		$11.9M Sell
169,049
-33,244
-16% -$3.25M 0.01% 1454
2015
Q2 		$22.5M Buy
202,293
+72,299
+56% +$7.79M 0.01% 1137
2015
Q1 		$12.3M Buy
+129,994
New +$14.6M 0.01% 1531

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank's AGIO Position: Q3 2025 in Review

Norges Bank sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 6,756 shares — an estimated $225K sold.

Norges Bank first reported a position in AGIO in Q1 2015 and held it in 42 quarters. The position peaked at $49.8M in Q4 2019. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Norges Bank reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 6,756 Agios Pharmaceuticals shares in Q3 2025, an estimated $225K.
  • Norges Bank first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 42 quarters.
  • Norges Bank's Agios Pharmaceuticals position peaked at $49.8M in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.